Glenmede Investment Management, LP Integra Lifesciences Holdings Corp Transaction History
Glenmede Investment Management, LP
- $20 Billion
- Q3 2025
A detailed history of Glenmede Investment Management, LP transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Glenmede Investment Management, LP holds 842,430 shares of IART stock, worth $9.9 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
842,430
Previous 682,192
23.49%
Holding current value
$9.9 Million
Previous $8.37 Billion
99.86%
% of portfolio
0.06%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding IART
# of Institutions
229Shares Held
79.4MCall Options Held
19.4KPut Options Held
0-
Black Rock Inc. New York, NY11.3MShares$132 Million0.01% of portfolio
-
Rubric Capital Management LP New York, NY7.65MShares$89.9 Million1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.38MShares$86.7 Million0.0% of portfolio
-
Eaton Vance Management Boston, MA4.22MShares$49.5 Million0.26% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA3.91MShares$46 Million0.2% of portfolio
About INTEGRA LIFESCIENCES HOLDINGS CORP
- Ticker IART
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 83,518,200
- Market Cap $981M
- Description
- Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...